Legend Biotech Files 6-K Report
Ticker: LEGN · Form: 6-K · Filed: Jun 3, 2025 · CIK: 1801198
| Field | Detail |
|---|---|
| Company | Legend Biotech Corp (LEGN) |
| Form Type | 6-K |
| Filed Date | Jun 3, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-K, compliance
TL;DR
Legend Biotech filed a routine 6-K, confirming their status as a foreign private issuer and commitment to Form 20-F filings.
AI Summary
Legend Biotech Corporation filed a Form 6-K on June 3, 2025, reporting as a foreign private issuer. The company is incorporated in E9 and has its principal executive offices in Somerset, New Jersey. Legend Biotech is required to file annual reports under cover of Form 20-F.
Why It Matters
This filing indicates Legend Biotech's ongoing compliance with SEC reporting requirements as a foreign private issuer, which is standard for companies with international operations.
Risk Assessment
Risk Level: low — This is a routine administrative filing and does not contain new financial or operational information that would typically impact risk.
Key Players & Entities
- Legend Biotech Corporation (company) — Filer of the Form 6-K
- 001-39307 (other) — SEC File Number
- 20250603 (date) — Date of Report
- 2101 Cottontail Lane Somerset, New Jersey 08873 (address) — Principal executive office address
FAQ
What type of report is Legend Biotech filing?
Legend Biotech is filing a Form 6-K, which is a Report of Foreign Private Issuer.
When was this report filed?
The report was filed on June 3, 2025.
What is Legend Biotech's SEC file number?
Legend Biotech's SEC file number is 001-39307.
Where are Legend Biotech's principal executive offices located?
Legend Biotech's principal executive offices are located at 2101 Cottontail Lane, Somerset, New Jersey 08873.
Does Legend Biotech file annual reports under Form 20-F or 40-F?
Legend Biotech indicates it files annual reports under cover of Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 3, 2025 regarding Legend Biotech Corp (LEGN).